Directory
>
Nathan Dowden
Nathan Dowden
President and Chief Operating Officer | Entrada Therapeutics
Boston, Massachusetts, United States
Nathan Dowden
Summary
Nathan Dowden is a seasoned executive with over 30 years of extensive experience in strategy, investment, and operations, primarily within the healthcare sector. As the President and Chief Operating Officer at Entrada Therapeutics, he has been instrumental in shaping the company's non-research functions and driving business development initiatives. His prior roles include leading corporate development at Rubius Therapeutics and serving as Managing Director at Huron Consulting, where he significantly grew the strategy practice. Nathan's expertise spans a wide range of areas including biotechnology, business strategy, and market analysis, showcasing his versatility in both startup and corporate environments. He has a strong track record of engaging with high-profile clients and has contributed to the development of innovative healthcare solutions. Additionally, Nathan holds dual citizenship in the US and the UK, which enriches his global perspective in business operations. He is also an inventor with five patents to his name, highlighting his commitment to innovation in life sciences.
Nathan Dowden
Work Experience
President and Chief Operating Officer at
Entrada Therapeutics
January 2024 - Present
Chief Operating Officer at
Entrada Therapeutics
November 2019 - December 2023
Senior Vice President, Corporate Development at
Rubius Therapeutics
March 2016 - November 2019
Managing Director at
Huron Consulting Group Inc.
January 2014 - March 2016
Managing Director at
Frankel Group
December 1997 - January 2014
Senior Consultant at
EY
June 1996 - December 1997
Nathan Dowden
Education
University of Chicago Booth School of Business, Mba
January 1994 - January 1996
University of Connecticut, Bs
January 1987 - January 1991
Frequently Asked Questions about Nathan Dowden
What is Nathan Dowden email address?
Nathan Dowden's primary email address is *******@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Nathan Dowden work for?
Nathan Dowden is a President and Chief Operating Officer at Entrada Therapeutics, a company specializing in Commercial physical research.
Where Nathan Dowden graduated from?
Nathan Dowden holds a degree in Finance from University of Chicago Booth School of Business.
How can I directly contact Nathan Dowden?
To contact Nathan Dowden directly, you can use the email address *******@entradatx.com. Complete contact information is available upon registration with Muraena.
Is Nathan Dowden an immigrant?
Yes, Nathan Dowden is an immigrant and currently based in United States
Who is Nathan Dowden?
Nathan Dowden is a seasoned executive with over 30 years of extensive experience in strategy, investment, and operations, primarily within the healthcare sector. As the President and Chief Operating Officer at Entrada Therapeutics, he has been instrumental in shaping the company's non-research functions and driving business development initiatives. His prior roles include leading corporate development at Rubius Therapeutics and serving as Managing Director at Huron Consulting, where he significantly grew the strategy practice. Nathan's expertise spans a wide range of areas including biotechnology, business strategy, and market analysis, showcasing his versatility in both startup and corporate environments. He has a strong track record of engaging with high-profile clients and has contributed to the development of innovative healthcare solutions. Additionally, Nathan holds dual citizenship in the US and the UK, which enriches his global perspective in business operations. He is also an inventor with five patents to his name, highlighting his commitment to innovation in life sciences.
Nathan`s contact details
*******@entradatx.com
*******@frankelgroup.com
Colleagues
Vice President
Executive Director, FP&A
Executive Director
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics
Chief Financial Officer and Treasurer
Board Member
Co-Founder & Vice President, Discovery Research
Vice President | Head of CMC
President Research And Development at Entrada Therapeutics
VP, Program Governance & Portfolio Management